Radiotherapy in acromegaly: a protagonists viewpoint.
Wass
J A H
JA
Department of Endocrinology, Oxford Centre for Diabetes, Endocrinology and Metabolism, Radcliffe Infirmary, Oxford, UK. john.wass@noc.anglox.nhs.uk
D000172:Acromegaly / Q000097:blood / Q000532:radiotherapy* / Q000601:surgery; D000236:Adenoma / Q000150:complications / Q000532:radiotherapy / Q000601:surgery; D015415:Biomarkers / Q000097:blood; D000075202:Contraindications; D013006:Growth Hormone / Q000097:blood; D006801:Humans; D007018:Hypopituitarism / Q000209:etiology; D007334:Insulin-Like Growth Factor I / Q000032:analysis; D018579:Patient Selection; D010910:Pituitary Irradiation / Q000009:adverse effects / Q000706:statistics & numerical data*; D010911:Pituitary Neoplasms / Q000150:complications / Q000532:radiotherapy / Q000601:surgery; D016634:Radiosurgery
D015415:Biomarkers; D007334:Insulin-Like Growth Factor I; D013006:Growth Hormone